SMAD4 and neoplasm: However, a tumor‐suppressive effect of TGF‐β1 was evident in most of the primary SMAD4 wild‐type PDTs in basal medium (PDT2‐5), while lines carrying mutations in the TGF‐β signaling pathway were less sensitive to TGF‐β1 treatment (PDT6,7,8).